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ABSTRACT Staphylococcus aureus is a facultative intracellular pathogen that invades
and replicates within many types of phagocytic and nonphagocytic cells. During in-
tracellular infection, S. aureus is capable of subverting xenophagy and escaping to
the cytosol of the host cell. Furthermore, drug-induced autophagy facilitates the in-
tracellular replication of S. aureus, but the reasons behind this are unclear. Here, we
have studied the host central carbon metabolism during S. aureus intracellular infec-
tion. We found extensive metabolic rerouting and detected several distinct meta-
bolic changes that suggested starvation-induced autophagic flux in infected cells.
These changes included increased uptake but lower intracellular levels of glucose
and low abundance of several essential amino acids, as well as markedly upregu-
lated glutaminolysis. Furthermore, we show that AMP-activated protein kinase
(AMPK) and extracellular signal-regulated kinase (ERK) phosphorylation levels are sig-
nificantly increased in infected cells. Interestingly, while autophagy was activated in
response to S. aureus invasion, most of the autophagosomes detected in infected
cells did not contain bacteria, suggesting that S. aureus induces the autophagic flux
during cell invasion for energy generation and nutrient scavenging. Accordingly,
AMPK inhibition halted S. aureus intracellular proliferation.
IMPORTANCE Staphylococcus aureus escapes from immune recognition by invading
a wide range of human cells. Once the pathogen becomes intracellular, the most
important last resort antibiotics are not effective. Therefore, novel anti-infective ther-
apies against intracellular S. aureus are urgently needed. Here, we have studied the
physiological changes induced in the host cells by S. aureus during its intracellular
proliferation. This is important, because the pathogen exploits the host cell’s metab-
olism for its own proliferation. We find that S. aureus severely depletes glucose and
amino acid pools, which leads to increased breakdown of glutamine by the host cell
in an attempt to meet its own metabolic needs. All of these metabolic changes acti-
vate autophagy in the host cell for nutrient scavenging and energy generation. The
metabolic activation of autophagy could be used by the pathogen to sustain its
own intracellular survival, making it an attractive target for novel anti-infectives.
KEYWORDS Staphylococcus aureus, autophagy, host cell, intracellular pathogen,
metabolism
The Gram-positive bacterium Staphylococcus aureus is a well-known opportunisticpathogen, thought to be carried by about one-third of the global human popula-
tion on the skin and/or in the nasal passages (1, 2), which act as a reservoir for infections
of the lower respiratory tract (3). S. aureus is considered one of the leading causes of
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hospital-acquired infections, although the number of community-associated S. aureus
infections has also increased in recent decades (4).
While S. aureus was originally considered an extracellular pathogen (5), it has since
been shown to be able to invade both phagocytic and nonphagocytic mammalian cells
(6–9). Mechanistically, invasion of non-professional phagocytes by S. aureus is achieved
via a zipper-type mechanism, involving fibronectin-binding proteins A and B (FnBPA
and FnBPB) (10–12). Several bacterial factors such as wall teichoic acids (WTAs), protein
A, and clumping factor B (ClfB) have also been shown to be important for host cell
invasion (9). Once S. aureus is internalized, it is able to persist and replicate within
phagosomes and, eventually, escape to the cytosol (9, 13), leading to the activation of
host cell death mechanisms such as apoptosis (14, 15).
Effective invasion and proliferation of intracellular pathogens are directly connected
to the metabolism of the host cell since the intracellular compartment in which the
pathogen resides becomes the space from which it imports nutrients in order to survive
and replicate (16, 17). Therefore, once bacteria have been internalized, both bacteria
and the host cell share—and compete for—the same nutrients (18, 19). Intracellular
pathogens have developed different mechanisms to acquire nutrients from the host
(18), by either altering host metabolic pathways (20), raising nutrient import (21), or
exploiting/subverting host mechanisms to degrade macromolecules such as autophagy
(22).
Autophagy is a catabolic mechanism that involves the formation of double-
membrane vesicles—autophagosomes—and subsequent lysosomal fusion to degrade
damaged or undesirable cytosolic material (23, 24). It is a well-conserved pathway in
eukaryotic cells and plays important physiological roles in response to nutrient starva-
tion, physiological stress, and recycling of organelles (24–26). Despite their names,
(auto)phagosomes are also involved in a common host response against intracellular
bacteria called xenophagy (27). It is known that a number of intracellular pathogens,
including S. aureus, can subvert xenophagy to persist within the autophagosomes
before escaping to the cytosol (28). However, it is not yet fully understood how
S. aureus achieves this and which host pathways and/or metabolites it uses to enhance
its intracellular survival and/or replication.
Treatment of S. aureus infections is significantly complicated by the ability of the
pathogen to establish intracellular infection (29) and thus evade large parts of the
host’s immune response, particularly if the emergence of multidrug-resistant strains,
such as methicillin-resistant S. aureus (MRSA), is taken into account (30, 31). MRSA is
resistant to many of the first-line antibiotics traditionally used to treat Gram-positive
bacteria, and the three “last resort” antibiotics routinely employed to treat MRSA
infection (vancomycin, daptomycin, and linezolid) are unable to enter the cell in
sufficient quantities to achieve intracellular killing (32). Therefore, there is an urgent
need to find novel therapies against this versatile pathogen. One strategy is to identify
and target host pathways essential for pathogen survival and proliferation (33, 34).
Our aim for this study was to understand the host cell metabolic changes induced
by MRSA infection with a view to identifying novel anti-infective strategies against
MRSA infections. We show that MRSA infection leads to changes in the metabolic fluxes
of the host cell. These changes lead to a starvation-like state in the host cell and the
subsequent activation of autophagy.
RESULTS
The extracellular metabolome of MRSA-infected host cells. We used nuclear
magnetic resonance (NMR) spectroscopy to analyze the medium composition during
gentamicin protection assays in HeLa cells exposed to both live and heat-killed
S. aureus USA300 cells. Results showed an increased concentration of organic acids in
the medium of infected cells with viable USA300 cells, such as formic, pyruvic, and
succinic acids. In particular, the highest increase was detected for acetic acid, with an
increase of more than 100-fold compared to uninfected cells (Fig. 1). Levels of some
amino acids (leucine, alanine, and methionine) were also increased in the medium of
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infected cells (Fig. 1). In contrast, glucose levels were significantly reduced compared to
those in the uninfected control (Fig. 1), suggesting more rapid glucose uptake. No
significant changes were found in the medium of cells infected with heat-killed
USA300, suggesting that the increased secretion of organic acids and the lower levels
of glucose were resulting from metabolic changes in the host cell triggered by viable
intracellular bacteria.
Changes in the host cell metabolism in response to MRSA infection. (i) Changes
in the central carbon metabolism after S. aureus USA300 infection. The intracellular
metabolome of MRSA-infected cells was analyzed by gas chromatography-mass spec-
trometry (GC-MS) (Fig. 2 and 3). We detected a major increase of several glycolytic
intermediates during MRSA invasion. Levels of both 3-phosphoglycerate (3-PG) and
phosphoenolpyruvate (PEP) were over 50 times higher in MRSA-infected cells com-
pared to uninfected cells or cells exposed to heat-killed bacteria (Fig. 2). In addition, the
glycerate pool size in the MRSA-infected cells significantly increased compared to that
of controls (Fig. 2). The labeling distribution of glycerate (Fig. 3) suggests that it was
formed from glycolytic 3-PG. In contrast, pyruvate levels only increased slightly in the
MRSA-infected cells, whereas lactate levels remained mostly unchanged among the
three conditions (Fig. 2).
Several tricarboxylic acid (TCA) cycle intermediates such as -ketoglutarate, citrate,
and succinate were present at higher levels in HeLa cells infected with USA300 (Fig. 2).
Interestingly, this increase was not universal, as levels of fumarate remained unchanged
among the three conditions and malate levels were reduced in cells infected with MRSA
(Fig. 2). Further, stable isotope tracing suggested that most of the carbon of succinate
is derived from glutamine; in contrast, the labeling patterns of fumarate and malate
showed an enhancement of glucose-derived label, suggesting an increased importance
of extramitochondrial pools of these metabolites. Interestingly, an increase in glucose-
derived carbon can also be seen in aspartate (Fig. 3). For both fumarate and aspartate,
this increase was due to a rise in the M3 isotope (see Fig. S1 at https://figshare.com/
s/e297ca2455dccb05307c).
FIG 1 Comparison of metabolites identified in the media after MRSA invasion. HeLa cells were exposed
to live and heat-killed USA300 cells (MOI of 100) for 6 h, and medium composition was analyzed by NMR
spectroscopy. Results are shown as log10 fold change relative to the uninfected condition, and the figure
shows means  standard errors from two independent experiments performed in triplicate. Striped bars
and black bars represent cells infected with live and heat-killed USA300 cells, respectively. Statistical
differences were tested using Student’s t test against uninfected cells. *, P  0.05; **, P  0.01; ***, P 
0.001.
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(ii) Amino acid metabolism. We observed an activation of glutaminolysis in HeLa
cells infected with USA300, with higher uptake of glutamine from the medium and
unchanged intracellular levels. In contrast, glutamate and alanine levels were signifi-
cantly higher in MRSA-infected cells than in uninfected cells or cells exposed to
heat-killed MRSA (Fig. 2). In the case of alanine, there is a slight increase of glucose-
derived label, indicating increased flux from pyruvate (Fig. 1 and 2).
FIG 2 Differences in the pool sizes of metabolites of the central carbon metabolism after S. aureus USA300 infection in HeLa cells.
HeLa cells were lysed after gentamicin protection assays with both live and heat-killed USA300 cells, and metabolites were detected
by GC-MS. Graphs show absolute levels of each metabolite in uninfected cells (U [white bars]), cells infected with the USA300 strain
(SA [striped bars]), and cells exposed to heat-killed USA300 (H [black bars]). The figure shows means  standard errors from two
independent experiments performed in triplicate. Statistical differences were tested using Student’s t test against uninfected cells. *,
P  0.05; **, P  0.01; ***, P  0.001. The y axis scale units are arbitrary units (1,000). Green arrows indicate metabolites of microbial
origin.
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Branched-chain amino acids are important for the virulence of S. aureus (35).
However, we have observed no differences in the levels of valine, leucine, and isoleu-
cine among the three experimental conditions (Fig. 4).
Importantly, the pool sizes of histidine, threonine, and serine (three essential amino
acids for both S. aureus and HeLa cells) were significantly reduced after USA300
infection (Fig. 4). In contrast, phenylalanine levels of infected cells were also in-
creased. While phenylalanine cannot be synthesized de novo by mammalian cells, MRSA
is able to synthesize phenylalanine from phenylpyruvate and histidine via HisC
(SAUSA300_0708), a histidinol-phosphate aminotransferase, potentially explaining both
higher levels of phenylalanine and lower levels of histidine in MRSA-infected cells.
FIG 3 Differences in the labeling patterns of metabolites of the central carbon metabolism after MRSA infection. HeLa cells were
infected with USA300 and exposed to heat-killed USA300 cells (MOI of 100) for 6 h. Metabolites and labeling distribution were
obtained by GC-MS. The figure illustrates the labeling pattern of each metabolite in uninfected cells (left pie chart), cells infected with
live USA300 cells (middle pie chart), and cells exposed to heat-killed USA300 cells (right pie chart). Pie charts depict the labeling
distribution, where blue sections represent carbon coming from a glucose-labeled source, red sections represent carbon coming from
a glutamine-labeled source, and white sections show carbon from other sources. Green arrows indicate metabolites of microbial origin.
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(iii) Changes in the central carbon metabolism after vancomycin protection
assays with S. aureus NCTC 13626. The significance of certain host-pathogen inter-
actions may vary depending on the cell line or bacterial strain tested (9). For example,
the metabolism of cancer cell lines is conditioned by the Warburg effect (36); therefore,
the metabolomics findings described in HeLa cells may not be applicable to primary
cells. To address this, we studied the metabolism of HeLa cells and BALB/c mouse bone
marrow macrophages when infected with MRSA strain NCTC 13626, a reference strain
for the health care-associated MRSA sequence type 239 (HA-MRSA ST239) lineage (37,
38). NCTC 13626 is resistant to gentamicin; therefore, the infection assays were carried
out in the presence of vancomycin. Interestingly, most of the changes induced in the
metabolism of both types of host cells tested with NCTC 13626 were in concordance
with the results observed in HeLa cells infected with USA300 (see Fig. S2 and S3 at
https://figshare.com/s/e297ca2455dccb05307c). The levels of glucose were reduced in
HeLa cells and bone marrow macrophages in response to NCTC 13626 infection (see
Fig. S2 and S3), whereas glutamate levels were significantly increased, especially in
bone marrow macrophages (Fig. S3), suggesting an activation of both the glycolysis
and glutaminolysis pathways. The increased levels of glycolytic intermediates were
found in HeLa cells irrespective of the infecting strain.
Similar to the USA300-infected cells, several metabolites from the TCA cycle such as
citrate and -ketoglutarate were significantly increased in NCTC 13626-infected cells
compared to uninfected controls (see Fig. S2 and S3 at https://figshare.com/s/
e297ca2455dccb05307c). The levels of succinate were also increased in HeLa cells
infected with NCTC 13626 (Fig. S2), whereas succinate levels were stable in bone
FIG 4 Changes in absolute levels of amino acids in HeLa cells after S. aureus USA300 infection. HeLa cells
were infected with USA300 and exposed to heat-killed USA300 cells (MOI of 100) for 6 h. Levels of amino
acids were detected and quantified by GC-MS. Graphs show absolute levels of each amino acid in
uninfected cells (U [white bars]), cells infected with live USA300 cells (SA [striped bars]), and cells exposed
to heat-killed S. aureus USA300 cells (H [black bars]). The figure shows means standard errors from two
independent experiments performed in triplicate. Statistical differences were tested using Student’s t test
against uninfected cells. *, P  0.05; **, P  0.01; ***, P  0.001. The y axis scale units are arbitrary units
(1,000).
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marrow macrophages (Fig. S3). In contrast with USA300 infection, levels both of
fumarate and malate were higher in HeLa cells and bone marrow macrophages when
infected with NCTC 13626, suggesting a strain-dependent metabolic change (see
Fig. S2 and S3).
Staphylococcal infection induces autophagy in HeLa cells. A number of the
metabolic changes we observed in this study have previously been linked to autophagy
(i.e., an increase in glutaminolysis and low levels of glucose and essential amino acids
may activate the autophagic flux in mammalian cells) (39). Further, autophagy/xe-
nophagy is a common host response against intracellular infection, where the autopha-
gosomes are employed to engulf intracellular bacteria for later degradation. However,
different studies have proved that S. aureus is able to survive and replicate within these
autophagosomes before escaping to the cytosol of the cell (9).
We therefore investigated autophagy status in our infection model. The conversion
of endogenous levels of LC3-I to LC3-II by Western blotting is a standard measure of
autophagy activation (40). Accordingly, the levels of conversion of LC3-I to LC3-II are
markedly increased in MRSA-infected HeLa cells compared to a noninfected control
(Fig. 5). However, after careful analysis by confocal microscopy, we observed that cells
with vacuoles staining positive for the autophagosomal marker mCherry-LC3 did not
necessarily colocalize with bacteria (Fig. 6). Furthermore, 45% of intracellular bacteria
were cytosolic at time point 6 h, which allows direct access to host metabolites
present in the cytosol, such as glucose (see Fig. S4 at https://figshare.com/s/e297
ca2455dccb05307c). As one of the main roles of autophagy is degradation of organelles
for energy generation and nutrient scavenging (41), we have studied the phosphory-
lation state of AMP-activated protein kinase (AMPK) and extracellular signal-regulated
kinase (ERK) during MRSA intracellular infection: AMPK and ERK are sensors of energy
stress and amino acid deprivation in mammalian cells.
AMPK is a key regulator in cellular energy homeostasis in eukaryotes, and this
pathway is activated when intracellular levels of ATP are low (42, 43). Furthermore, a
drop of amino acids in eukaryotic cells has been linked to a stimulation of autophagy
by activating the Ras/Raf1/ErkI/II pathway (44).
Therefore, we quantified the levels of AMPK and ErkI/II on MRSA-infected cells, and
we found that both pathways were activated in response to bacterial infection in HeLa
cells. Basal levels of ErkI/II and AMPK were increased in HeLa cells infected with MRSA;
however, the levels of the phosphorylated versions of both proteins were even higher
FIG 5 MRSA infection induces autophagy in HeLa cells. (A) HeLa cells were infected with the USA300
strain (MOI of 100) for 6 h, and protein lysates were analyzed by Western blotting against LC3. The figure
shows that MRSA infection promotes autophagy by activating the conversion of LC3-I to LC3-II. Both
actin and GAPDH antibodies were employed as loading controls. The figure is a representative example
of three independent experiments. (B) Quantification of the conversion of LC3-I to LC3-II in uninfected
and infected HeLa cells. Data are expressed as means standard errors from three different experiments,
and t tests were performed to validate statistical significance across conditions. U (white bar), uninfected
cells; SA (black bar), S. aureus-infected cells. **, P  0.01.
Intracellular MRSA Metabolomics
July/August 2018 Volume 3 Issue 4 e00374-18 msphere.asm.org 7
 o
n
 August 20, 2018 by guest
http://m
sphere.asm
.org/
D
ow
nloaded from
 
(Fig. 7A). Thus, ratios of phospho-AMPK/AMPK and phospho-ErkI/ErkII were, respec-
tively, 4 and 1.7 times higher than those in the noninfected control (Fig. 7B).
To further validate these results, we tested the effect of dorsomorphin—an AMPK
inhibitor (45)—on MRSA infection in human umbilical vein endothelial cells (HUVECs)
and HeLa cells. We first confirmed that dorsomorphin has no direct effect on USA300
FIG 6 Colocalization assay of MRSA-GFP and mCherry-LC3A by confocal microscopy. (A) Uninfected HeLa cells expressing mCherry-LC3A. (B) HeLa
cells expressing mCherry-LC3A infected with the USA300-GFP strain (MOI of 100 for 6 h); DAPI was employed for nucleus staining. The MRSA-free
autophagosomes were detected around the whole cell. (C) Quantification of percentage of cells containing MRSA-free autophagosomes in
uninfected (U [white bar]) and S. aureus-infected (SA [black bar]) HeLa cells. Data are expressed as means  standard errors from three different
experiments, and t tests were performed to validate statistical significance across conditions. ***, P  0.001.
FIG 7 An activation of the p-AMPK and p-ERK2 pathway was detected in MRSA-infected cells. HeLa cells were infected with
USA300 cells (MOI of 100) for 6 h. (A) Protein lysates were analyzed by Western blotting against AMPK, phosphorylated
AMPK (p-AMPK), p44/42 MAPK (ErkI/II), and phospho-p42/44 AMPK (p-ERK). -Actin antibody was employed as a loading
control. (B) Quantification of the phospho-AMPK/AMPK and phospho-ErkI/ErkII ratios. Data were normalized to -actin
levels for each condition. Data are expressed as means standard errors from three different experiments, and t tests were
performed to validate statistical significance across conditions. U (white bars), uninfected cells; SA (black bars), S. aureus-
infected cells. *, P  0.05; **, P  0.01.
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growth (see Fig. S5 at https://figshare.com/s/e297ca2455dccb05307c). We then tested
the effect of dorsomorphin on the cell viability of USA300-infected cells. High concen-
trations of dorsomorphin did not restore host cellular viability during infection, indi-
cating that this drug can be cytotoxic at high doses to mammalian cells (Fig. 8A).
FIG 8 AMPK inhibition increases cell viability while reducing intracellular MRSA survival and autophagy levels.
HeLa cells and HUVECs were infected with USA300 (MOI of 100) for 6 h in the presence or absence of
dorsomorphin. (A and E) Host cell viability after USA300 infection was quantified by flow cytometry in HeLa cells
and HUVECs, respectively. (B and F) intracellular MRSA survival was measured by CFU counting in agar plates in
HeLa cells and HUVECs, respectively. (C) Protein lysates were analyzed by Western blotting against LC3I/II, AMPK,
and phosphor-AMPK (p-AMPK). -Actin antibody was employed as a loading control. (D) Quantification of the
conversion of LC3-I to LC3-II. Data are expressed as means standard errors from three different experiments, and
t tests were performed to validate statistical significance across conditions. U (stippled bars), uninfected. *, P 0.05;
***, P  0.001.
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However, in the presence of 2 M dorsomorphin, host cell viability was increased in
comparison to that of a nontreated control, whereas intracellular MRSA survival was
inhibited after 6 h of infection in both cell lines (Fig. 8). Specifically, the effect of AMPK
inhibition on MRSA intracellular survival was more pronounced in HUVECs than in HeLa
cells. Furthermore, the levels of conversion of LC3-I to LC3-II were also significantly
reduced in dorsomorphin-treated cells compared to nontreated cells after MRSA infec-
tion (Fig. 8C and D).
DISCUSSION
MRSA intracellular infection leads to extensive metabolic rerouting leading to
the host exhibiting signs of metabolic starvation. In this study, we were interested
in the metabolic changes brought about by intracellular infection of nonphagocytic
cells. We performed NMR and MS-based profiling and found that intermediates of lower
glycolysis—such as phosphoenolpyruvate (PEP) and 3-phosphoglycerate (3-PG)—were
highly increased in HeLa cells infected with the USA300 strain of S. aureus. Although the
absolute levels of PEP and 3-PG were raised in HeLa cells after infection with the
USA300 strain, the levels of lactate were relatively unaffected in both intracellular and
extracellular compartments. Interestingly, the levels of intracellular pyruvate were
increased in HeLa cells infected with the USA300 strain, and the secretion of this
metabolite to the medium was also elevated in infected cells. This is suggestive of a
downstream block explaining the accumulation of PEP and 3-PG. While the nature of
this block is unknown, potential targets include (partial) inhibition of pyruvate kinase,
the mitochondrial pyruvate carrier, and/or the pyruvate dehydrogenase complex, as
well as regulatory interference of pyruvate dehydrogenase kinases.
In stark contrast, MRSA-infected cells excreted vastly increased quantities of acetate
and formate. Acetate excretion is not uncommon in HeLa cell infection models as a
product of bacterial activity (46), and our findings suggest elevated flux through
bacterial pyruvate-formate lyase (Pfl). Pfl generates formate and acetyl coenzyme A
(acetyl-CoA), which has been shown to be converted to acetate via phosphate acetyl-
transferase (Pta) and acetate kinase (AckA) for ATP generation (47) under some condi-
tions. Furthermore, the increases in excretion (Fig. 1) and labeling patterns in USA300-
infected cells (Fig. 3) for both formate and acetate are similar to each other and to those
of pyruvate, suggesting a common source. These results suggest that despite higher
glucose uptake in infected cells, bacterial metabolism might subvert some of the
carbon intake, possibly contributing to a starvation response. While Pfl activity has
mainly been activated under anaerobic conditions and in biofilms (48), intracellular Pfl
activity might be a hallmark of intracellular S. aureus proliferation that warrants future
investigation.
Among all the metabolic changes generally seen in host cells after an intracellular
infection, alterations of the TCA cycle are relatively common (17, 49). The TCA cycle
represents an important source of carbons and chemical energy for intracellular
pathogens (18); therefore, it is likely that intracellular pathogens exploit this pathway
for their intracellular survival and proliferation. In this study, the TCA cycle was greatly
affected by MRSA infection, regardless of the strain or cell line employed. While
glutamine was the main source of carbon for most of the intermediates, there was a
clear rise in the glucose-derived label in fumarate and aspartate of infected cells. The
reason for this difference in label distributions between fumarate/aspartate and succi-
nate is not fully clear, but it could arise via several pathways. As the increase in
glucose-derived label was mainly due to an increase in the M3 ion (see Fig. S1 at
https://figshare.com/s/e297ca2455dccb05307c), this suggests an anaplerotic flux from
either pyruvate or PEP. One possibility is increased flux through pyruvate carboxylase
forming oxaloacetate, potentially as a consequence of reduced flux through succinate
dehydrogenase (Sdh), as previously observed in a study looking at the metabolic effects
of loss-of-function sdh mutants (50). Moreover, the same study also found amino acid
pool size alterations similar to those seen in the present study (50). Given the high
levels of PEP, it is also possible that the reaction of PEP carboxykinase might be
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reversed: it usually catalyzes the decarboxylation of oxaloacetate to PEP during gluco-
neogenesis (51). On its own, however, this would not explain the difference between
fumarate and malate labeling patterns. In addition, the increase in glutaminolysis that
we have detected will increase the availability of ammonium, which can be used to
convert oxaloacetate to aspartate, and this in turn is converted to fumarate in the urea
cycle. Activation of the urea cycle is imminently plausible due to increased amounts of
glutamate, an activator of N-acetylglutamate synthase, the product of which,
N-acetylglutamate, is a key positive regulator of urea cycle activity (52).
MRSA-induced starvation initiates an autophagy response that is exploited by
the bacteria. Among all its physiological functions, the role of autophagy as a defense
against intracellular pathogens has been widely described (25, 27, 53, 54). However,
intracellular pathogens have developed refined mechanisms to subvert autophagy/
xenophagy and successfully survive within mammalian host cells (55–57). For instance,
Salmonella enterica serovar Typhimurium and Mycobacterium tuberculosis inhibit the
autophagy initiation signaling (58, 59), whereas Shigella flexneri escapes from au-
tophagy recognition by recruiting Toca-1 via IcsB to inhibit its recognition by the
autophagy machinery (60, 61). In contrast, S. aureus was shown to be able to replicate
in autophagosomes and to eventually escape to the host cytosol (28, 62), although the
molecular mechanisms behind this are not yet fully understood. However, our analysis
revealed that a significant number of autophagosomes do not contain bacteria in
MRSA-infected cells, suggesting that these autophagosomes may have been formed for
an alternative purpose.
Autophagy inhibition with wortmannin impairs the intracellular proliferation of
S. aureus, whereas the induction of autophagy by rapamycin results in an increased
number of intracellular bacteria (28). On the other hand, autophagy confers cellular
protection to the alpha-toxin produced by S. aureus (63). However, the alpha-toxin is
not sufficient to permeabilize phagosomes in HeLa cells, probably reflecting differences
in expression in the receptor of alpha-toxin monomers, the ADAM10 metalloprotease
(9, 64, 65). Therefore, we hypothesize here that MRSA-free autophagosomes could be
produced in response to a different autophagy-inducing stimulus than leaky phago-
somes containing bacterial cells or the alpha-toxin produced by the pathogen.
The role of autophagy as a host defense pathway against intracellular pathogens has
been already questioned, since the replication of some bacteria was impaired in
autophagy-deficient cells and the treatment with autophagy activators recovered
bacterial replication (66). Considering that autophagy could increase nutrient access,
intracellular pathogens may have evolved some mechanisms to manipulate host
autophagosomes and to exploit the products of autophagic degradation for bacterial
survival and proliferation (22, 67). Intracellular MRSA causes multiple changes in cellular
metabolism during infection, and many of the changes we observed point toward a
situation of starvation, probably induced by the pathogen. This state of induced
starvation might explain the presence of numerous MRSA-free autophagosomes.
In response to nutrient deprivation, autophagy is induced in mammalian cells (41,
44). This process is mainly regulated by mammalian target of rapamycin (mTOR), which
acts as a sensor of the host metabolic state (68). In a wide range of mammalian cell
lines, low levels of glucose enhance the autophagic machinery (44), whose regulation
is usually dependent on AMPK signaling (69). During glucose deprivation, the proau-
tophagy Beclin 1/VPS34 complex is activated via AMPK-dependent Beclin 1 phosphor-
ylation (70). Moreover, a drop in the amino acid levels also induces autophagy in
mammalian cells via the Ras/Raf-1/ErkI/II signaling pathway (44, 71). Additionally, in
response to low levels of glucose, glutaminolysis is activated to sustain the TCA cycle
and ATP production (44). As a consequence of the ammonia produced by the glutami-
nolysis pathway, the autophagic flux is increased (72, 73). In HeLa cells infected with the
USA300 strain, all these starvation signals were present: reduction in the levels of
glucose, a drop in several amino acids, and activation of glutaminolysis pathway.
Interestingly, these changes were also observed in both HeLa cells and BALB/c mouse
bone marrow macrophages infected with an alternative health care-associated MRSA
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(HA-MRSA) strain, suggesting that the results previously mentioned are not just strain
and host dependent. In addition, we also observed activation of both AMPK and ERK
signaling pathways in HeLa cells after MRSA infection. In accordance with these
findings, a recent study has shown that the levels of ATP in human alveolar epithelial
cells were significantly decreased during early time points of S. aureus infection (74),
further pointing to a starvation-induced response. Crucially, once we inhibited the host
AMPK pathway using dorsomorphin, intracellular MRSA survival was significantly ham-
pered and autophagy levels were decreased, supporting our hypothesis that the
activation of autophagy is caused by the state of starvation induced by the intracellular
pathogen, and this autophagy benefits the intracellular survival of MRSA. Future studies
need to be carried out to identify additional components of this regulatory pathway,
but our findings suggest a novel host-directed antistaphylococcal strategy based on
the inhibition of AMPK-mediated autophagy.
Conclusions. In this study, we have observed that autophagy may be activated in
response to the metabolic state of the MRSA-infected host cell. During MRSA intracel-
lular proliferation, the levels of glucose and several amino acids are significantly
decreased in the host cell (likely due to bacterial metabolic activity), whereas glutami-
nolysis is highly activated. These observations are indicative of a state of starvation
induced by the pathogen, which would explain the production of MRSA-free autopha-
gosomes observed in infected host cells. This hypothesis is also supported by the
activation of AMPK and ERK pathways, which act, respectively, as key sensors of cellular
energy homeostasis and amino acid deprivation. In addition, we have identified AMPK
as a new drug target for the development of alternative anti-infective compounds to
traditional antibiotherapy against staphylococcal infection.
MATERIALS AND METHODS
Bacterial strains, cell lines, and culture conditions. S. aureus USA300 LAC (75) and NCTC 13626
were cultured in nutrient broth (NB) (Sigma-Aldrich). Routinely, cells were grown for preinocula in 50-ml
cultures to an optical density at 600 nm (OD600) of 1, centrifuged and washed with phosphate-buffered
saline (PBS), and resuspended in 1.5 ml of PBS supplemented with 20% glycerol, and aliquots of 100 l
were stored at 80°C until further use. The CFU per milliliter of the preinocula was calculated by serial
dilution plating.
HeLa cells (ECACC 93021013) were grown in Dulbecco’s modified Eagle’s medium (DMEM [Gibco])
containing pyruvate, glucose, and glutamine and supplemented with 10% heat-inactivated fetal bovine
serum (FBS [Gibco]) and 5% penicillin and streptomycin solution (Gibco), unless otherwise stated. BALB/c
mouse bone marrow macrophages (supplied by Calltag Medsystems) were cultured on complete
macrophage medium supplemented with granulocyte-macrophage colony-stimulating factor, penicillin,
streptomycin, and fetal bovine serum (Calltag Medsystems). Human umbilical vein endothelial cells
(HUVECs [Sigma]) were grown in endothelial cell growth medium (Sigma).
HeLa cells expressing mCherry-LC3 (HeLa_mChe-LC3) were created by transduction (protocol from
Boada-Romero et al. [76]). P12-MMP-mCherry-LC3 was kindly supplied by Felipe X. Pimentel Muiños
(Centro de Investigación del Cancer de Salamanca, Spain). mCherry-LC3 was replaced with mCherry-CWT.
Briefly, CWT was amplified from pLVTHM-Pm_YFPCWT (a kind gift from Martin Fraunholz, Würzburg,
Germany) with primers GACGAGCTGTACAAGGGCTCGAGCCCATCA and TAGCTAGCGGCCGCTTTACTTTAT
AGTTCCCCAAAG, whereas mCherry was amplified with TAGCTAAAGCTTGCCACCATGGTGAGCAAGGG
CGAG and TGATGGGCTCGAGCCCTTGTACAGCTCGTC, and subjected to fusion PCR. The resulting DNA
amplicon was verified by sequencing, digested with HindIII/NotI, and cloned into P12-MMP.
For carbon labeling experiments for gas chromatography-mass spectrometry (GC-MS), minimum
essential medium (MEM) containing 10% heat-inactivated FBS was supplemented with either unlabeled
or universally 13C-labeled glucose or glutamine.
Intracellular infection assay. For metabolomics approaches, mammalian cells were seeded in 6-well
plates (Sarstedt) in complete medium without antibiotics at a cell density of 5  105 cells per well. The
cells were infected after overnight adherence using 1 ml of fresh medium containing diluted S. aureus
preinocula at a multiplicity of infection (MOI) of 100 and incubated at 37°C in 5% CO2 for 45 min. For the
heat-killed condition, bacteria were incubated for 10 min at 95°C prior to centrifugation. After initial
incubation, media were replaced by complete medium supplemented with 100 g/ml gentamicin and
cells were incubated for five additional hours, when the number of intracellular bacteria doubled while
the host cell viability was halved (see Fig. S6A and B at https://figshare.com/s/e297ca2455dccb05307c).
S. aureus NCTC 13626 is resistant to gentamicin (Fig. S6C); for that reason, gentamicin was replaced
during NCTC 13626 infection assays with 5 g/ml vancomycin, a clinically relevant antibiotic that is not
active against intracellular S. aureus (32).
For host cell viability and bacterial survival, the intracellular infection assay was performed in 96- and
24-well plates, respectively. Host cell viability was quantified by flow cytometry with a fluorescein
isothiocyanate (FITC)-annexin V apoptosis detection kit I (BD), following the manufacturer’s recommen-
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dations. Intracellular bacterial survival was quantified by lysing the cells with 100 l of 0.1% Triton X-100
and quantifying CFU in agar plates.
Metabolomics. (i) Extracellular metabolome analysis. After 6 h of infection, medium was sampled
and centrifuged (2,000 rpm, 5 min, 4°C), and the supernatant was stored immediately at 80°C. For
analysis by nuclear magnetic resonance (NMR) spectroscopy, 0.8 ml of cell supernatant was mixed with
0.2 ml of NMR buffer (1 mM 4,4-dimethyl-4-silapentane-1-sulfonic acid [DSS] and 25 mM NaN3 in 2H2O,
resulting in final concentrations of 0.2 and 5 mM, respectively). 1H NMR spectroscopy was performed on
a Bruker DRX400 Avance spectrometer (Bruker Biospin, Rheinstetten, Germany) with a magnetic field
strength of 9.4 T and a resonance frequency of 400 MHz. Spectra were acquired at 298 K into 32-K data
points using a one-dimensional solvent suppression sequence, as described by Beckonert et al. (77).
(ii) Intracellular metabolome analysis. Cells were washed with 1 ml of ice-cold Ringer’s solution
(Oxoid) after 6 h of infection, quenched by adding 1 ml of cold (20°C) methanol, detached by using a
cell scraper, and immediately stored at 80°C (78).
To obtain separated organic and aqueous fractions, extracts were dried using an Eppendorf Vacufuge
concentrator, and a dual-phase extraction was performed by adding 300 l of CHCl3/MeOH (2:1) and
vortexing for 30 s. After addition of 300 l of water and centrifugation (13,000 rpm, 10 min, room
temperature), the top aqueous layer was transferred into an inactivated glass vial and dried before being
stored at 80°C. The lower organic layers were placed into glass vials and dried overnight before being
stored at 80°C.
For GC-MS, samples were derivatized by a two-step methoximation-silylation derivatization proce-
dure. For normalization, a standard of 10 l of 1.5 mg/ml myristic acid d27 standard solution (Sigma-
Aldrich) was added and samples were dried. The dried samples were first methoximated using 20 l of
20 mg/ml methoxyamine hydrochloride in anhydrous pyridine at 37°C for 90 min. For unlabeled samples,
this was followed by silylation with 80 l of N-methyl-N-(trimethylsilyl) trifluoroacetamide (MSTFA) at
37°C for 30 min (79). Labeled samples were derivatized by adding 80 l of N-(tert-butyldimethylsilyl)-
N-methyltrifluoroacetamide (MBTSFA [Thermo Scientific]). After being vortexed, samples were placed in
a heater block at 70°C for 1 h. Eventually samples were centrifuged at 2,000 rpm for 5 min prior to
transferring them into a clean vial for GC-MS analysis.
GC-MS analysis was performed on an Agilent 7890 gas chromatograph equipped with a 30-m
DB-5MS capillary column with a 10-m Duraguard column connected to an Agilent 5975 MSD operating
under electron impact ionization (Agilent Technologies UK, Ltd.). Samples were injected with an Agilent
7693 autosampler injector into deactivated splitless liners according to the method of Kind et al. (79),
using helium as the carrier gas. Metabolites in the unlabeled pool were identified and quantified using
a workflow described by Behrends et al. (80). Briefly, samples were deconvoluted in AMDIS (79, 81) and
quantified using an in-house script. Integration of labeled metabolites was carried out based on an
in-house fragment/retention time database using an updated version of the MatLab script capable of
natural isotope correction (80, 82).
Immunoproteomic approaches. (i) Cell extractions and protein lysates. Cells were harvested by
adding ice-cold phosphate-buffered saline (PBS) and detached by using a cell scraper (Thermo Fisher
Scientific). Cell suspensions were transferred to 15-ml Falcon tubes and centrifuged (2,000 rpm, 10 min,
4°C). Cell pellets were washed with ice-cold PBS and immediately placed on ice for cell lysis. Lysis buffer
(50 mM Tris [pH 7.5], 150 mM NaCl, 5 mM EDTA, 1% NP-40 detergent) was reconstituted with protease
and phosphatase inhibitor cocktails (Sigma-Aldrich) and phenylmethylsulfonyl fluoride (PMSF [Sigma-
Aldrich]), following the manufacturer’s instructions. Cell pellets were resuspended in 50 l of lysis buffer,
transferred to Eppendorf tubes, and incubated on ice for 30 min, applying heavy vortexing every 10 min.
Then samples were centrifuged at maximum speed for 5 min at 4°C, and supernatants were transferred
to new Eppendorf tubes and immediately stored at 80°C until needed.
The protein concentration was quantified by using the DC protein assay kit (Bio-Rad), and every cell
lysate was adjusted to same concentration by diluting each sample in lysis buffer.
(ii) SDS-PAGE. Cell extractions were mixed with 2 reducing sample buffer (100 mM Tris [pH 6.8],
10% -mercaptoethanol, 4% SDS, 0.3% bromophenol blue, 20% glycerol) and boiled in a heat block at
100°C for 5 min. Samples were loaded on polyacrylamide gels using 1 running buffer (25 mM Tris, 20
mM glycine, 0.05% SDS) and run on a Mini-Protean Tetra electrophoresis system (Bio-Rad) with a
constant voltage of 100 V for 90 min.
(iii) Western blotting and antibody detection. Primary antibodies were purchased from Sigma
(anti--actin [reference no. A5316]), Santa Cruz Biotechnologies (anti-GAPDH [reference no. sc-47724]),
Fisher (anti-LC3 [reference no. 13278218]), and Cell Signalling Technology (anti-AMPK [reference no.
2793], anti-p-AMPK [reference no. 2535], anti-ERK [reference no. 4695], and anti-p-ERK [reference
no. 5726]). Secondary antibodies were purchased from Li-Cor (IRDye 680LT goat anti-mouse [reference
no. 926-68070] and IRDye 800LT goat anti-rabbit [reference no. 926-32211]).
Proteins were transferred onto nitrocellulose membranes (GE Healthcare) by using a Mini Trans-Blot
cell (Bio-Rad) with 1 transfer buffer (25 mM Tris, 192 mM glycine, 20% methanol) and Whatman filter
paper (GE Healthcare), following the manufacturer’s guidelines. The Western blot was run on the Tetra
electrophoresis system at a constant voltage of 90 V for 2 h.
Nitrocellulose membranes were blocked using 5% skim milk diluted in Tris-buffered saline (TBS)
solution (50 mM Tris [pH 7.6], 150 mM NaCl) for 1 h at room temperature. Once the blocking solution was
removed, membrane was washed twice with TBS containing 0.05% Tween 20 (TBST) and subsequently
incubated overnight at 4°C with the primary antibody. Following the suppliers’ recommendations, the
primary antibodies were diluted to 1:1,000 in TBST containing 2% bovine serum albumin (BSA) and 0.1%
sodium azide. After three washes with TBST, the membrane was incubated with the corresponding
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secondary antibody diluted 1:5,000 in 5% skim milk–TBST for 1 h at room temperature. The membrane
was washed again three times with TBST and was developed employing the Odyssey Fc imaging system
(Li-Cor). Images were taken, processed, and quantified by using Image Studio software (Li-Cor).
Immunofluorescence microscopy. HeLa cell lines expressing mCherry-LC3 were seeded in cover-
slips at a cell density of 7  104 cells per well, and green fluorescent protein-expressing S. aureus strain
USA300 (USA300-GFP) (83) was used to infect the cells at an MOI of 100. Infection was performed as
previously described (76), and after 6 h of infection, cells were fixed with 0.5 ml of fresh 4% of
paraformaldehyde (PFA) for 15 min. Coverslips were then washed twice with PBS and mounted on slides
using ProLong Gold antifade mountant with DAPI (4=,6-diamidino-2-phenylindole [Thermo Fisher Scien-
tific]) for nuclear staining.
Slides were observed on a confocal microscope Zeiss LSM 800 with Airyscan. Images were acquired
and processed by using Zen Blue software (Zeiss).
Statistical analysis. Statistical analysis was conducted using GraphPad Prism software. Student’s
t test and post hoc Tukey’s multiple-comparison tests were employed to examine significant differences
across treatments.
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